Pharmacogenetics The study of how an individual s genetic - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Pharmacogenetics The study of how an individual s genetic

Description:

Pharmacogenetics The study of how an individual s genetic inheritance affects the body s response to drugs. The study of genetic variation underlying differential ... – PowerPoint PPT presentation

Number of Views:180
Avg rating:3.0/5.0
Slides: 21
Provided by: djusdK12
Category:

less

Transcript and Presenter's Notes

Title: Pharmacogenetics The study of how an individual s genetic


1
Pharmacogenetics
The study of how an individuals genetic
inheritance affects the bodys response to drugs.
The study of genetic variation underlying
differential response to drugs.
Branch of pharmaceutics which aims to tailor
medicines to an individuals genetic makeup.
Is a form of individualized medicine.
2
The Herceptin Story
3
  • HER2 is a proto-oncogene found on chromosome 17.

HER2
4
  • HER2 stands for Human Epidermal growth factor
    Receptor 2. Each normal breast cell contains
    copies of the HER2 gene, which helps normal cells
    grow. The HER2 gene is found in the DNA of a
    cell, and this gene contains the information for
    making the HER2 protein.

5
  • The HER2 protein, also called the HER2
    receptor, is found on the surface of some normal
    cells in the body. In normal cells, HER2 proteins
    help send growth signals from outside the cell to
    the inside of the cell. These signals tell the
    cell to grow and divide.

6
  • In HER2 breast cancer, the cancer cells have
    an abnormally high number of HER2 genes per cell.
    When this happens, too much HER2 protein appears
    on the surface of these cancer cells. This is
    called HER2 protein overexpression.

7
  • Too much HER2 protein is thought to cause
    cancer cells to grow and divide more quickly.
    This is why HER2 breast cancer is considered
    aggressive.

8
Testing a tumor for HER2 using FISH or
Immunohistochemistry (IHC)
9
HER2 FISH
In this procedure, the chromosome 17 centromere
is marked with a green florescent signal and
HER-2 gene with an orange florescent signal. 60
non-overlapping tumor cell nuclei are counted and
the number of green and orange signals are
assessed in each cell. Then, the overall
gene-to-chromosome (17) ratio is calculated. A
tumor is designated as positive for gene
amplification if gene-to-chromosome (17) ratio is
gt2.0
10
(No Transcript)
11
(No Transcript)
12
Research
13
Trastuzumab (Herceptin)
  • The drug Herceptin was discovered by Dennis
    Slamon at UCLA in 1998 and manufactured by
    Genentech scientists.
  • It blocks the action of the receptor

14
  • Trastuzumab was originally developed in mice,
    as a mouse antibody. Because humans have immune
    reactions to mouse proteins, it was later
    developed into a human (humanized) antibody.
  • Because the antibodies were produced from one
    cell that was grown into a clone of identical
    cells, it is called a monoclonal antibody.

15
Animation
16
COST
  • 70,000 for a full course of treatment
  • Genentech earned 327 million in 2007 4thQ

17
Another HER2 drug
Animation
18
Support Groups
19
An example of a KaplanMeier plot for two
conditions associated with patient survival
20
Kaplan-Meier Curve, Herceptin
Write a Comment
User Comments (0)
About PowerShow.com